TruScreen Group Investor Relations Material

TruScreen Group Limited is a New Zealand-based medical technology company specializing in the development and commercialization of real-time cervical cancer screening devices. The company’s flagship product uses proprietary sensor technology and algorithms to detect precancerous and cancerous cells in cervical tissue, providing an alternative to traditional smear tests. TruScreen’s devices are designed for use in various healthcare settings, particularly in regions with limited access to laboratory-based screening methods, aiming to improve early detection and accessibility. The company is headquartered in Auckland, New Zealand, and its shares are listed on the NZX.